Kendle

Synteract appoints Kelson as CFO, Doren as vice president of biometrics

Wednesday, January 30, 2013 03:18 PM

Synteract, a full service CRO based in Carlsbad, Calif., has hired new executives to support customers on a global scale. Keith Kelson will serve as chief financial officer and member of its executive council, and Phil Doren has been appointed vice president of biometrics.

More... »

INC Research to close Old Lyme office

Wednesday, March 28, 2012 11:12 AM

INC Research, a CRO based in Raleigh, N.C., will be closing its Old Lyme office in Connecticut, laying off 66 employees in the process, according to the filing at the State of Connecticut Labor Department.

More... »

CRO top executives in a game of ‘musical chairs’

Monday, November 7, 2011 08:02 AM

Five months after INC Research’s acquisition of Kendle International closed, executives from the now-combined CRO are landing jobs with competitors.  

More... »

Survey: Top CROs doubled workforce over past decade

Monday, October 24, 2011 08:02 AM

Over the last 10 years, the top nine global CROs have more than doubled their workforce, which now exceeds 72,000 employees, and their revenues have increased at a compound annualized rate of 11% as they increasingly play a larger and more integral role in the drug development infrastructure, according to a new Association of Clinical Research Organizations (ACRO) member survey.

More... »

Carlyle Partners, Hellman & Friedman to acquire PPD for $3.9 billion, take the CRO private

Monday, October 10, 2011 08:02 AM

It’s official: Large equity investors Carlyle Partners and Hellman & Friedman Capital Partners are buying publicly traded PPD, taking the CRO private.

More... »

PRA on the block, too?

Monday, August 8, 2011 08:02 AM

There was much hoopla made about PPD possibly being for sale after the Wall Street Journal published a story saying as much in mid-July. But what about its smaller competitor, PRA International?

More... »

PPD shares rise on takeover rumors

Monday, July 18, 2011 01:51 PM

Shares of CRO Pharmaceutical Product Development (PPD) rose 16% to levels not touched in more than two-and-a-half years on Monday, a day after a Wall Street Journal report said the company was looking to sell itself, reported Reuters.

More... »

INC Research completes acquisition of Kendle International

Wednesday, July 13, 2011 10:31 AM

Raleigh, N.C.-based INC Research, a therapeutically focused CRO privately held by Avista Capital Partners and Ontario Teachers’ Pension Plan, has completed the acquisition of Kendle International in an all-cash transaction with a total equity value of approximately $232 million or $15.25 per share.

More... »

Kendle names Dr. Pierre Geoffroy vice president, early stage

Friday, June 10, 2011 11:12 AM

Cincinnati-based CRO Kendle has appointed Pierre Geoffroy, M.D., C.M., MSc, FCFP vice president, early stage, effective immediately.  Dr. Geoffroy brings nearly two decades of clinical development experience to the position.  He will oversee the development of early stage programs for customers worldwide, providing medical expertise and clinical insights for the development of safe and effective early-stage clinical trials.  Dr. Geoffroy will be based out of Kendle's early stage unit in Toronto and will report directly to Stephen Cutler, Ph.D., president and CEO.

More... »

INC Research to acquire Kendle in all-cash deal to help compete for strategic deals with big pharma

Monday, May 9, 2011 09:38 AM

After months of rumors about Kendle International being on the block, CRO INC Research late last week announced it would buy the mid-tier publicly held CRO in an all-cash transaction. If the deal goes through, Kendle will be taken private.

More... »